trending Market Intelligence /marketintelligence/en/news-insights/trending/S5KlhYwjWFUdWHFf9AxwAQ2 content esgSubNav
In This List

CorMedix appoints director

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021

Blog

Post-webinar Q&A: Global Credit Risk Trends 2021 and Beyond

Blog

University Essentials: From Crisis to Resilience – Navigating Sustainable Recovery


CorMedix appoints director

CorMedix Inc.'s board elected Gary Gelbfish as a director, effective Aug. 3, to serve until the 2018 annual meeting.

Gelbfish currently serves as CEO and chairman of Metrodora Therapeutics LLC, a clinical stage biotechnology company.